Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Medication spend represents a major expense for hospitals, especially amid ever-increasing drug prices.
AbbVie, Biogen pull multiple sclerosis drug from the market citing safety concerns: 4 things to know
Drugmakers Biogen and AbbVie voluntarily withdrew their multiple sclerosis drug Zinbryta from the global market, following eight reported cases of brain inflammation in patients using the medication, reports Reuters.
Here are the three latest drugs or medical devices approved by the FDA this week.
The FDA approved Medtronic's Resolute Onyx drug-eluting stent Feb. 26 — making it the smallest drug-eluting stent on the U.S. market, according to the Star Tribune.
Medtronic signed a five-year partnership deal with Lehigh Valley Health Network, an eight-hospital organization in Allentown, Pa., to improve patient outcomes and minimize costs, CNBC reports.
The FDA approved a non-opioid painkiller patch for nerve pain associated with shingles Feb. 28, according to Reuters.
The FDA approved expanded use for Eli Lilly's treatment for advanced or metastatic breast cancer Feb. 26.
Deerfield, Ill.-based Walgreens Boots Alliance and AmerisourceBergen have reportedly ended acquisition discussions without an agreement, sources familiar with the matter told CNBC.
Alia Paavola and Alyssa Rege
When I started this “Champions of Change” series, I wrote about the importance of bringing diverse teams together and tapping into their strengths and knowledge. Being a Champion of Change isn’t just about your own great ideas — it’s also…
Mark Graban
As part of a plan to reduce its $32.5 billion debt burden, Teva Pharmaceuticals closed offices in New York City and Washington D.C., according to The Calcalist.